KALV KalVista Pharmaceuticals Inc
2,416
$11.67
$0.42
(3.73%)
| Watchers | 2,416 |
| 52-Wk Low | $7.21 |
| 52-Wk High | $16.88 |
| Market Cap | $492.34M |
| Volume | 234,800.00 |
| 52-Wk High | $16.88 |
| 52-Wk Low | $7.21 |
KalVista Pharmaceuticals Announces New England Journal of Medicine Publishes Oral Sebetralstat Phase 3 Data Demonstrating its Potential to Transform the Treatment Landscape for People with Hereditary AngioedemaBusiness Wire • 3 days ago
KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), today announced that late-breaking data from the pivotal phase 3 KONFIDENT trial and open label KONFIDENT-S extension trial evaluating the efficacy and...
Share to Feed
KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of oral, small molecule protease inhibitors, today...
KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), today announced that the compensation committee of KalVistas board of directors granted ten newly-hired employees inducement options to purchase an...
KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), today announced its strategic plans for fiscal year 2025, beginning May 1, including for sebetralstat, the Companys investigational novel, oral plasma...
KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of oral, small molecule protease inhibitors, today...
KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of oral, small molecule protease inhibitors, today...
KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), today announced that the compensation committee of KalVistas board of directors granted nine newly-hired employees inducement options to purchase an...
KalVista Pharmaceuticals, Inc. (NASDAQ:KALV - Get Free Report) saw unusually-strong trading volume on Thursday . Approximately 1,665,708 shares traded hands during mid-day trading, an increase of...
This is a signal that KALV's price could be shifting from a downtrend to an uptrend. Traders may consider buying the stock or exploring call options...
This is a signal that KALV's price could be shifting from a downtrend to an uptrend. Traders may consider buying the stock or exploring call options...